<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Corporate Growth on FinanClub</title>
    <link>https://finan.club/tags/corporate-growth/</link>
    <description>Recent content in Corporate Growth on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 02 Sep 2023 03:06:06 +0000</lastBuildDate><atom:link href="https://finan.club/tags/corporate-growth/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>BSX</title>
      <link>https://finan.club/us/bsx/</link>
      <pubDate>Sat, 02 Sep 2023 03:06:06 +0000</pubDate>
      
      <guid>https://finan.club/us/bsx/</guid>
      <description>score:12
Chances: Boston Scientific&amp;rsquo;s (BSX) FARAPULSE System Study Data Positive Boston Scientific Surges As It Looks To Enter A Market Worth Nearly $8 Billion Boston Scientific Leads the S&amp;amp;P 500 Boston Scientific Reports Positive Results from Atrial Fibrillation Device ADVENT Study of the FARAPULSEâ„¢ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints Risks: Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year EVP &amp;amp; Grp Pres, MedSurg &amp;amp; APAC Arthur Butcher Sells 6,600 Shares of Boston Scientific &amp;hellip; Ozempic Is All the Rage.</description>
    </item>
    
  </channel>
</rss>
